Regulators of Ca 2+ signaling in mast cells: Potential targets for treatment of mast cell-related diseases?

Advances in Experimental Medicine and Biology

Volumn 716, Issue , 2011, Pages 62-90

  Ma, Hong Tao ^a   Beaven, Michael A ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOETHOXYDIPHENYLBORANE; ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM CHANNEL AFFECTING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; ISOENZYME; PHOSPHOLIPASE C; PHOSPHOLIPASE C BETA; PHOSPHOLIPASE C GAMMA; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SODIUM CALCIUM EXCHANGE PROTEIN; SPHINGOSINE KINASE; SPHINGOSINE KINASE 1; SPHINGOSINE KINASE 2; STROMAL INTERACTION MOLECULE 1; STROMAL INTERACTION MOLECULE 2; SYNTA 66; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; TRANSIENT RECEPTOR POTENTIAL CHANNEL M4; UNCLASSIFIED DRUG; YM 58483; PROTEIN KINASE;

ALLERGIC REACTION; ARTICLE; ASTHMA; AUTOIMMUNE DISEASE; CALCIUM DEPLETION; CALCIUM METABOLISM; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL ACTIVATION; CELL MEMBRANE TRANSPORT; CELL POLARITY; CONTACT ALLERGY; CROSS COUPLING REACTION; CYTOKINE PRODUCTION; CYTOSOLIC FRACTION; DELAYED HYPERSENSITIVITY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG TARGETING; ENDOPLASMIC RETICULUM; ENTERITIS; ENZYME MECHANISM; EOSINOPHILIA; EXTRACELLULAR CALCIUM; GOLGI COMPLEX; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOPATHOLOGY; INFLAMMATORY CELL; INFLAMMATORY DISEASE; ION EXCHANGE; MAST CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; MOLECULAR INTERACTION; MOLECULAR PROBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STORE OPERATED CALCIUM ENTRY CHANNEL; ANIMAL; ENZYMOLOGY; HOMEOSTASIS; MASTOCYTOSIS; METABOLISM; REVIEW;

ANIMALS; CALCIUM SIGNALING; HOMEOSTASIS; HUMANS; MAST CELLS; MASTOCYTOSIS; PROTEIN KINASES;

EID: 79960898896     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-9533-9_5     Document Type: Article

References (258)

1. 2+signaling with particular focus on mast cells. Crit Rev Immunol 2009; 29:155-86.
2. Hoth M, Penner R. Depletion of intracellular calcium stores activates a calcium current in mast cells. Nature 1992; 355:353-6.
3. Hoth M, Penner R. Calcium release-activated calcium current in rat mast cells. J Physiol (Lond) 1993: 465:359-86. (Pubitemid 23201401)
4. Hundley TR, Gilfillan AM, Tkaczyk C et al. Kit and FceRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells. Blood 2004; 104:2410-7. (Pubitemid 39331841)
5. Ali H, Cunha-Melo JR, Saul WF et al. The activation of phospholipase C via adenosine receptors provides synergistic signals for secretion in antigen stimulated RBL-2H3 cells: Evidence for a novel adenosine receptor. J Biol Chem 1990; 265:745-53.
6. Feoktistov I, Biaggioni I. Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. J Clin Invest 1995; 96:1979-86.
7. Linden J, Thai T, Figler H et al. Characterization of human A2B adenosine receptors: radioligand binding, western blotting and coupling to Gq in human embryonic kidney 293 cells and HMC-1 mast cells. Mol Pharmacol 1999; 56:705-13. (Pubitemid 29491171)
8. Nguyen M, Solle M, Audoly LP et al. Receptors and signaling mechanisms required for prostaglandin E2-mediated regulation of mast cell degranulation and IL-6 production. J Immunol 2002; 169:4586-93. (Pubitemid 35178238)
9. Kuehn HS, Beaven MA, Ma HT et al. Synergistic activation ofphospholipasesCy and Cp: a novel mechanism for PI3K-independent enhancement ofFceRI-induced mast cell mediator release. Cell Signal 2008; 20:625-36.
10. Ali H, Sozzani S, Fisher I et al. Differential regulation of formyl peptide and platelet-activating factor receptors. Role of phospholipase Cp phosphorylation by protein kinase A. JBiol Chem 1998; 273:11012-6.
11. Hartmann K, Henz BM, Kruger-Krasagakes S et al. C3a and C5a stimulate chemotaxis of human mast cells. Blood 1997; 89:2863-70. (Pubitemid 27172573)
12. Qiao H, Andrade MV, Lisboa FA et al. FceRI and Toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells. Blood 2006; 107:610-8. (Pubitemid 43076385)
13. Beaven MA, Rogers J, Moore JP et al. The mechanism of the calcium signal and correlation with histamine release in 2H3 cells. J Biol Chem 1984; 259:7129-36. (Pubitemid 14077793)
14. 2+and purifiedisozymes in washed permeabilized cells. JBiol Chem 1993; 268:1749-56. (Pubitemid 23033568)
15. 2+influx through CRAC channels activates cytosolic phospholipase A2, leukotriene C4 secretion and expression of c-fos through ERK-dependent and -independent pathways in mast cells. FASEB J 2006; 20:2381-3.
16. 2+influx. Curr Biol 2005; 15:1235-41. (Pubitemid 40950523)
17. 2+channel function. J Cell Biol 2005; 169:435-45. (Pubitemid 40686694)
18. Feske S, Gwack Y, Prakriya M et al. A mutation in Orail causes immune deficiency by abrogating CRAC channel function. Nature 2006; 441:179-85.
19. 2+entry. Science 2006; 312:1220-3. (Pubitemid 43801149)
20. 2+channel activity. Proc Natl Acad Sci USA 2006; 103:9357-62. (Pubitemid 43902581)
21. Soboloff J, Spassova MA, Tang XD et al. Orai1 and STIM reconstitute store-operated calcium channel function. J Biol Chem 2006; 281:20661-5. (Pubitemid 44115407)
22. Mercer JC, Dehaven WI, Smyth JTet al. Large store-operated calcium selective currents due to co-expression of Orai1 or Orai2 with the intracellular calcium sensor, Stim1. J Biol Chem 2006; 281:24979-90. (Pubitemid 44274268)
23. Peinelt C, Vig M, Koomoa DL et al. Amplification of CRAC current by STIM1 and CRACM1 (Orail). Nat Cell Biol 2006; 8:771-3.
24. Lichtenstein LM, Osler AG. Studies on the mechanism of hypersensitiviy phenomena: IX. Histamine release from human leukocytes by ragweed pollen. J Exp Med 1964; 120:507-30.
25. Greaves MW, Mongar JL. The mechanism of anaphylactic histamine release from rabbit leucocytes. Immunology 1968; 15:743-9.
26. Foreman JC, Mongar JL. The role of the alkaline earth ions in anaphylactic histamine secretion. J Physiol (Lond) 1972; 224:753-69.
27. Riley JF. The Mast Cells. Edinburgh and London: E. and S. Livingstone; 1959.
28. Foreman JC, Hallett MB, Mongar JL. Movement of strontium ions into mast cells and its relationship to the secretory response. J Physiol (Lond) 1977; 271:233-51. (Pubitemid 8178796)
29. Foreman JC, Hallet MB, Mongar JL. The relationship between histamine secretion and 45calcium-uptake by mast cells. J Physiol 1977; 271:193-214. (Pubitemid 8178794)
30. Foreman JC, Mongar JL. The action of lanthanum and manganese on anaphylactic histamine secretion. Br J Pharmacol 1973; 48:527-37.
31. Pearce FL, White JR. Effect of lanthanide ions on histamine secretion from rat peritoneal mast cells. Br J Pharmacol 1981; 72:341-7. (Pubitemid 11130400)
32. Mohr FC, Fewtrell C. Depolarization of rat basophilic leukemia cells inhibits calcium uptake and exocytosis. J Cell Biol 1987; 104:783-92. (Pubitemid 17024732)
33. Millard PJ, Ryan TA, Webb WW et al. Immunoglobulin E receptor cross-linking induces oscillations in intracellular free ionized calcium in individual tumor mast cells. J Biol Chem 1989; 264:19730-9. (Pubitemid 20008081)
34. Jones SV, Choi OH, Beaven M.A. Carbachol induces secretion in a mast cell line (RBL-2H3) transfected with the m1 muscarinic receptor gene. FEBS Lett 1991; 289:47-50.
35. Marcotte GV, Millard P J, Fewtrell C. Release of calcium from intracellular stores in rat basophilic leukemia cells monitored with the fluorescent probe chlortetracycline. J Cell Physiol 1990; 142:78-88.
36. Hide M, Beaven M.A. Calcium influx in a rat mast cell (RBL-2H3) line: Use of multivalent metal ions to define its characteristics and role in exocytosis. J Biol Chem 1991; 266:15221-9. (Pubitemid 21907638)
37. Mohr FC, Fewtrell C. The effect of mitochondrial inhibitors on calcium homeostasis in tumor mast cells. Am J Physiol 1990; 258:C217-C226. (Pubitemid 20094617)
38. 2+stores. Biochem J 1994; 304:431-40.
39. Mohr FC, Fewtrell C. The relative contributions of extracellular and intracellular calcium to secretion from tumor mast cells. Multiple effects of the proton ionophore carbonyl cyanide m-chlorophenylhydrazone. J Biol Chem 1987; 262:10638-43. (Pubitemid 17127046)
40. Streb H, Bayerd:orffer E, Haase W et al. Effect of inositol-1,4,5- trisphosphate on isolated subcellular fractions of rat pancreas. J Membr Biol 1984; 81:241-53. (Pubitemid 14015991)
41. Furuichi T, Yoshikawa S, Miyawaki A et al. Primary structure and functional expression of the inositol 1,4,5-trisphosphate-binding protein P400. Nature 1989; 342:32-8. (Pubitemid 19271115)
42. Mignery GA, Newton CL, Archer BT III et al. Structure and expression ofthe rat inositol 1,4,5-trisphosphate receptor. J Biol Chem 1990; 265:12679-85.
43. Lytton J, Westlin M, Hanley MR. Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps. J Biol Chem 1991; 266:17067-71. (Pubitemid 21907906)
44. 2+stores by specific inhibition of the endoplasmic reticulum Ca2+-ATPase. Proc Natl Acad Sci USA 1990; 87:2466-70.
45. Takemura H, Hughes AR, Thastrup O et al. Activation of calcium entry by the tumor promoter thapsigargin in parotid acinar cells. Evidence that an intracellular calcium pool and not an inositol phosphate regulates calcium fluxes at the plasma membrane. J Biol Chem 1989; 264:12266-71. (Pubitemid 19191112)
46. 2+without generation ofinositol phosphates in NG115- 401L neuronal cells. Biochem J 1988; 253:81-6.
47. Putney JW Jr. Recent breakthroughs in the molecular mechanism of capacitative calcium entry (with thoughts on how we got here). Cell Calcium 2007; 42:103-10. (Pubitemid 47029594)
48. 2+influx pathway that is permeable to sodium and manganese. J Cell Physiol 1995; 164:205-13.
49. 2+and degranulation in a rat mast cell line. J Immunol 2008; 180:2233-9.
50. 2+responses in mast cells. J Immunol 2009; 183:6478-88.
51. Cheng KT, Liu X, Ong HL et al. Functional requirement for Orai1 in store-operated TRPC1-STIM1 channels. J Biol Chem 2008; 283:12935-40.
52. Liao Y, Erxleben C, Abramowitz J et al. Functional interactions among Orai1, TRPCs and STIM1 suggest a STIM-regulated heteromeric Orai/TRPC model for SOCE/Icrac channels. Proc Natl Acad Sci USA 2008; 105:2895-900. (Pubitemid 351723640)
53. Beaven MA, Moore JP, Smith GA et al. The calcium signal and phosphatidylinositol breakdown in 2H3 cells. J Biol Chem 1984; 259:7137-42. (Pubitemid 14077794)
54. Pribluda VS, Metzger H. Calcium-independent phosphoinositide breakdown in rat basophilic leukemia cells. Evidence for an early rise in inositol 1,4,5-trisphosphate which precedes the rise in other inositol phosphates and in cytoplasmic calcium. J Biol Chem 1987; 262:11449-54.
55. Park DJ, Min HK, Rhee SG. IgE-induced tyrosine phosphorylation of phospholipase C-y1 in rat basophilic leukemia cells. J Biol Chem 1991; 266:24237-40. (Pubitemid 21908930)
56. Ali H, Fisher I, Haribabu B et al. Role of phospholipase Cp phosphorylation in the desensitization of cellular responses to platelet-activating factor. J Biol Chem 1997; 272:11706-9. (Pubitemid 27202733)
57. Choi OH, Lee JH, Kassessinoff T et al. Carbachol and antigen mobilize calcium by similar mechanisms in a transfected mast cell line (RBL-2H3 cells) that expresses m1 muscarinic receptors. J Immunol 1993; 151:5586-95. (Pubitemid 23332368)
58. Mazel T, Raymond R, Raymond-Stintz M et al. Stochastic modeling of calcium in 3D geometry. Biophys J 2009; 96:1691-706.
59. Barker SA, Caldwell KK, Pfeiffer JRet al. Wortmannin-sensitive phosphorylation, translocation and activation of PLCy1, but not PLCy2, in antigen-stimulated RBL-2H3 mast cells. Mol Biol Cell 1998; 9:483-96. (Pubitemid 28084139)
60. Saitoh S, Arudchandran R, Manetz TS et al. LAT is essential for FceRI-mediated mast cell activation. Immunity 2000; 12:525-35.
61. Tkaczyk C, Beaven MA, Brachman SM et al. The phospholipase Cy1-dependent pathway of FceRI-mediated mast cell activation is regulated independently of phosphatidylinositol 3-kinase. J Biol Chem 2003; 278:48474-84. (Pubitemid 37523303)
62. Gilfillan AM, Tkaczyk C. Integrated signalling pathways for mast-cell activation. Nat Rev Immunol 2006; 6:218-30. (Pubitemid 43290991)
63. Parravinci V, Gadina M, Kovarova M et al. Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat Immunol 2002; 3:741-8.
64. Thompson HL, Marshall CJ, Saklatvala J. Characterization of two different forms of mitogen-activated protein kinase kinase induced in polymorphonuclear leukocytes following stimulation by N-formylmethionyl-leucyl-phenylalanine or granulocyte-macrophage colony-stimulating factor. J Biol Chem 1994; 269:9486-92.
65. Kuehn HS, Gilfillan AM. G protein-coupled receptors and the modification of FceRI-mediated mast cell activation. Immunol Lett 2007; 113:59-69. (Pubitemid 47562126)
66. Thudichum JLW. A Treatise on the Chemical Constitution of the Brain. London: Bailliere, Tindall and Cox; 1884.
67. Sourkes TL. The Life and Work of J. L. W. Thudichum, 1829-1901: "A Most Celebrated Exponent of the Art of Medicine and Chemistry". Montreal: Osler Libray, McGill University; 2003.
68. Beaven M.A. Division of labor: Specialization of sphingosine kinases in mast cells. Immunity 2007; 26:271-3. (Pubitemid 46413911)
69. Meyer zu Heringdorf D. Lysophospholipid receptor-dependent and -independent calcium signaling. J Cell Biochem 2004; 92:937-48. (Pubitemid 44264243)
70. Choi OH, Kim JH, Kinet JP. Calcium mobilization via the sphingosine kinase in signalling by the FceRI antigen receptor. Nature 1996; 380:634-6. (Pubitemid 26119017)
71. 2+signals triggered by different phospholipid pathways in antigen stimulation of human mast cells. J Biol Chem 2002; 277:17255-62. (Pubitemid 34967760)
72. Olivera A, Mizugishi K, Tikhonova A et al. The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. Immunity 2007; 26:287-97. (Pubitemid 46413904)
73. Mitra P, Oskeritzian CA, Payne SG et al. Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc Natl Acad Sci USA 2006; 103:16394-9. (Pubitemid 44715207)
74. Oskeritzian CA, Price MM, Hait NC et al. Essential roles of sphingosine-1-phosphate receptor 2 in human mast cell activation, anaphylaxis and pulmonary edema. J Exp Med 2010; 207:465-74.
75. Jolly PS, Bektas M, Olivera A et al. Transactivation of Sphingosine-1-Phosphate Receptors by FceRI Triggering Is Required for Normal Mast Cell Degranulation and Chemotaxis. J Exp Med 2004; 199:959-70. (Pubitemid 38481087)
76. Olivera A, Urtz N, Mizugishi K et al. IgE-dependent activation of spingosine kinase 1 and 2 and secretion of sphingosine-1-phosphate requires Fyn kinase and contributes to mast cell responses. J Biol Chem 2006; 281:2515-25. (Pubitemid 43845711)
77. 2+mobilization via a sphingosine kinase pathway in a clathrin-dependent manner. Cell Calcium 2009; 45:99-108.
78. Hait NC, Oskeritzian CA, Paugh SW et al. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim Biophys Acta 2006; 1758:2016-26. (Pubitemid 44879368)
79. Rivera J, Proia RL, Olivera A. The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat Rev Immunol 2008; 8:753-63.
80. Melendez AJ. Allergy therapy: the therapeutic potential of targeting sphingosine kinase signalling in mast cells. Eur J Immunol 2008; 38:2969-74.
81. Vermassen E, Parys JB, Mauger JP. Subcellular distribution of the inositol 1,4,5-trisphosphate receptors: functional relevance and molecular determinants. Biol Cell 2004; 96:3-17. (Pubitemid 38240394)
82. 2+stores. Curr Opin Cell Biol 2005; 17:135-40.
83. Devogelaere B, Verbert L, Parys JB et al. The complex regulatory function of the ligand-binding domain of the inositol 1,4,5-trisphosphate receptor. Cell Calcium 2008; 43:17-27.
84. Choe CU, Ehrlich BE. The inositol 1,4,5-trisphosphate receptor (IP3R) and its regulators: sometimes good and sometimes bad teamwork. Sci STKE 2006; 2006:re15.
85. Patterson RL, Boehning D, Snyder SH. Inositol 1,4,5-trisphosphate receptors as signal integrators. Annu Rev Biochem 2004; 73:437-65. (Pubitemid 39050376)
86. 2+binding proteins in RBL-2H3 rat basophilic leukemia cells. Cell Calcium 1997; 22:475-86. (Pubitemid 28051056)
87. Wilson BS, Pfeiffer JR, Smith AJ et al. Calcium-dependent clustering of inositol 1,4,5-trisphosphate receptors. Mol Biol Cell 1998; 9:1465-78. (Pubitemid 28303490)
88. 2+mobilization by mediating the interaction between type I inositol 1,4,5-trisphosphate receptor, RACK1 and Orai1. J Biol Chem 2010; 285:8045-53.
89. Mikoshiba K. The IP3 receptor/Ca2+ channel and its cellular function. Biochem Soc Symp 2007:9-22.
90. Tu H, Wang Z, Bezprozvanny I. Modulation of mammalian inositol 1,4,5-trisphosphate receptor isoforms by calcium: a role of calcium sensor region. Biophys J 2005; 88:1056-69. (Pubitemid 40975938)
91. 2+release by reversible phosphorylation and dephosphorylation. Biochim Biophys Acta 2009; 1793:959-70.
92. Jayaraman T, Ondrias K, Ondriasova E et al. Regulation of the inositol 1,4,5-trisphosphate receptor by tyrosine phosphorylation. Science 1996; 272:1492-4. (Pubitemid 26200002)
93. Yokoyama K, Su II, Tezuka T et al. BANK regulates BCR-induced calcium mobilization by promoting tyrosine phosphorylation of IP3 receptor. EMBO J 2002; 21:83-92. (Pubitemid 34087077)
94. Echevarria W, Leite MF, Guerra MT et al. Regulation of calcium signals in the nucleus by a nucleoplasmic reticulum. Nat Cell Biol 2003; 5:440-6. (Pubitemid 36592267)
95. 2+store, with functional properties distinct from those ofthe endoplasmic reticulum. EMBO J 1998; 17:5298-308. (Pubitemid 28427045)
96. Turner H, Fleig A, Stokes A et al. Discrimination of intracellular calcium store subcompartments using TRPV1 (transient receptor potential channel, vanilloid subfamily member 1) release channel activity. Biochem J 2003; 371:341-50. (Pubitemid 36547616)
97. Huang Y, Putney JW Jr. Relationship between intracellular calcium store depletion and calcium release-activated calcium current in a mast cell line (RBL-1). J Biol Chem 1998; 273:19554-9. (Pubitemid 28367008)
98. 2+channel activation in liver cells: evidence from studies using TRPV1 and taurodeoxycholic acid. Biochem J 2009; 418:553-66.
99. 2+store. J Biol Chem 2007; 282:12176-85. (Pubitemid 47100720)
100. Olivera A, Mizugishi K, Tikhonova A et al. The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. Immunity 2007; 26:287-97. (Pubitemid 46413904)
101. Mitra P, Oskeritzian CA, Payne SG et al. Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc Natl Acad Sci USA 2006; 103:16394-9. (Pubitemid 44715207)
102. Oskeritzian CA, Price MM, Hait NC et al. Essential roles of sphingosine-1-phosphate receptor 2 in human mast cell activation, anaphylaxis and pulmonary edema. J Exp Med 2010; 207:465-74.
103. Jolly PS, Bektas M, Olivera A et al. Transactivation of Sphingosine-1-Phosphate Receptors by FceRI Triggering Is Required for Normal Mast Cell Degranulation and Chemotaxis. J Exp Med 2004; 199:959-70. (Pubitemid 38481087)
104. Olivera A, Urtz N, Mizugishi K et al. IgE-dependent activation of spingosine kinase 1 and 2 and secretion of sphingosine-1-phosphate requires Fyn kinase and contributes to mast cell responses. J Biol Chem 2006; 281:2515-25. (Pubitemid 43845711)
105. 2+mobilization via a sphingosine kinase pathway in a clathrin-dependent manner. Cell Calcium 2009; 45:99-108.
106. Hait NC, Oskeritzian CA, Paugh SW et al. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim Biophys Acta 2006; 1758:2016-26. (Pubitemid 44879368)
107. Rivera J, Proia RL, Olivera A. The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat Rev Immunol 2008; 8:753-63.
108. Melendez AJ. Allergy therapy: the therapeutic potential of targeting sphingosine kinase signalling in mast cells. Eur J Immunol 2008; 38:2969-74.
109. Vermassen E, Parys JB, Mauger JP. Subcellular distribution of the inositol 1,4,5-trisphosphate receptors: functional relevance and molecular determinants. Biol Cell 2004; 96:3-17. (Pubitemid 38240394)
110. 2+stores. Curr Opin Cell Biol 2005; 17:135-40.
111. Devogelaere B, Verbert L, Parys JB et al. The complex regulatory function of the ligand-binding domain of the inositol 1,4,5-trisphosphate receptor. Cell Calcium 2008; 43:17-27.
112. Choe CU, Ehrlich BE. The inositol 1,4,5-trisphosphate receptor (IP3R) and its regulators: sometimes good and sometimes bad teamwork. Sci STKE 2006; 2006:re15.
113. Patterson RL, Boehning D, Snyder SH. Inositol 1,4,5-trisphosphate receptors as signal integrators. Annu Rev Biochem 2004; 73:437-65. (Pubitemid 39050376)
114. 2+binding proteins in RBL-2H3 rat basophilic leukemia cells. Cell Calcium 1997; 22:475-86. (Pubitemid 28051056)
115. Wilson BS, Pfeiffer JR, Smith AJ et al. Calcium-dependent clustering of inositol 1,4,5-trisphosphate receptors. Mol Biol Cell 1998; 9:1465-78. (Pubitemid 28303490)
116. 2+mobilization by mediating the interaction between type I inositol 1,4,5-trisphosphate receptor, RACK1 and Orai1. J Biol Chem 2010; 285:8045-53.
117. Mikoshiba K. The IP3 receptor/Ca2+ channel and its cellular function. Biochem Soc Symp 2007:9-22.
118. Tu H, Wang Z, Bezprozvanny I. Modulation of mammalian inositol 1,4,5-trisphosphate receptor isoforms by calcium: a role of calcium sensor region. Biophys J 2005; 88:1056-69. (Pubitemid 40975938)
119. 2+release by reversible phosphorylation and dephosphorylation. Biochim Biophys Acta 2009; 1793:959-70.
120. Jayaraman T, Ondrias K, Ondriasova E et al. Regulation of the inositol 1,4,5-trisphosphate receptor by tyrosine phosphorylation. Science 1996; 272:1492-4. (Pubitemid 26200002)
121. Yokoyama K, Su II, Tezuka T et al. BANK regulates BCR-induced calcium mobilization by promoting tyrosine phosphorylation of IP3 receptor. EMBO J 2002; 21:83-92. (Pubitemid 34087077)
122. Echevarria W, Leite MF, Guerra MT et al. Regulation of calcium signals in the nucleus by a nucleoplasmic reticulum. Nat Cell Biol 2003; 5:440-6. (Pubitemid 36592267)
123. 2+store, with functional properties distinct from those ofthe endoplasmic reticulum. EMBO J 1998; 17:5298-308. (Pubitemid 28427045)
124. Turner H, Fleig A, Stokes A et al. Discrimination of intracellular calcium store subcompartments using TRPV1 (transient receptor potential channel, vanilloid subfamily member 1) release channel activity. Biochem J 2003; 371:341-50. (Pubitemid 36547616)
125. Huang Y, Putney JW Jr. Relationship between intracellular calcium store depletion and calcium release-activated calcium current in a mast cell line (RBL-1). J Biol Chem 1998; 273:19554-9. (Pubitemid 28367008)
126. 2+channel activation in liver cells: evidence from studies using TRPV1 and taurodeoxycholic acid. Biochem J 2009; 418:553-66.
127. 2+store. J Biol Chem 2007; 282:12176-85. (Pubitemid 47100720)
128. 2+entry. J Biol Chem 2006; 281:35855-62. (Pubitemid 46041317)
129. 2+sensory region of STIM1 and STIM2. Biochem Biophys Res Commun 2008; 369:240-6.
130. 2+store to the plasma membrane. Nature 2005; 437:902-5. (Pubitemid 41486767)
131. 2+entry: local activation of CRAC channels by STIM1 at ER-plasma membrane junctions. J Cell Biol 2006; 174:815-25. (Pubitemid 44373731)
132. 2+stores and on electrostatic interactions. Mol Biol Cell 2008; 20:389-99.
133. Muik M, Fahrner M, Derler I et al. A cytosolic homomerization and a modulatory domain within STIM1 C-terminus determine coupling to ORAI1 channels. J Biol Chem 2009; 284:8421-6.
134. 2+influx by interacting with the C-terminal acidic coiled coil of Orai1. Biochemistry 2010; 49:1067-71.
135. 2+channel activation. J Biol Chem 2007; 282:29448-56. (Pubitemid 350043387)
136. Park CY, Hoover PJ, Mullins FM et al. STIM1 clusters and activates CRAC channels via direct binding of a cytosolic domain to Orai1. Cell 2009; 136:876-90.
137. Muik M, Frischauf I, Derler I et al. Dynamic coupling of the putative coiled-coil domain of ORAI1 with STIM1 mediates ORAI1 channel activation. J Biol Chem 2008; 283:8014-22.
138. Mathes C, Fleig A, Penner R. Calcium release-activated calcium current (ICRAC) is a direct target for sphingosine. J Biol Chem 1998; 273:25020-30. (Pubitemid 28443258)
139. Yuan JP, Zeng W, Huang GN et al. STIM1 heteromultimerizes TRPC channels to determine their function as store-operated channels. Nat Cell Biol 2007; 9:636-45. (Pubitemid 47214725)
140. Zeng W, Yuan JP, Kim MS et al. STIM1 gates TRPC channels, but not Orai1, by electrostatic interaction. Mol Cell 2008; 32:439-48.
141. Stathopulos PB, Zheng L, Ikura M. Stromal Interaction Molecule (STIM) 1 and STIM2 Calcium Sensing Regions Exhibit Distinct Unfolding and Oligomerization Kinetics. J Biol Chem 2009; 284:728-32.
142. Oh-Hora M, Yamashita M, Hogan PG et al. Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T-cell activation and tolerance. Nat Immunol 2008; 9:432-43. (Pubitemid 351405113)
143. Parvez S, Beck A, Peinelt C et al. STIM2 protein mediates distinct store-dependent and store-independent modes of CRAC channel activation. FASEB J 2008; 22:752-61. (Pubitemid 351348128)
144. Nilius B, Owsianik G, Voets T et al. Transient receptor potential cation channels in disease. Physiol Rev 2007; 87:165-217. (Pubitemid 46207713)
145. Parekh AB, Putney JW Jr. Store-operated calcium channels. Physiol Rev 2005; 85:757-810. (Pubitemid 40404641)
146. Putney JW, Bird GS. Cytoplasmic calcium oscillations and store-operated calcium influx. J Physiol 2008; 586:3055-9. (Pubitemid 351984689)
147. Ambudkar IS, Ong HL. Organization and function of TRPC channelosomes. Pflugers Arch 2007; 455:187-200. (Pubitemid 47546783)
148. Vazquez G, Wedel BJ, Aziz O, Trebak M, Putney JW, Jr. The mammalian TRPC cation channels. Biochim Biophys Acta 2004; 1742:21-36. (Pubitemid 39610491)
149. Kiselyov K, Kim JY, Zeng W et al. Protein-protein interaction and function: TRPC channels. Pflugers Arch 2005; 451:116-24. (Pubitemid 41424914)
150. Putney JW Jr. Inositol lipids and TRPC channel activation. Biochem Soc Symp 2007:37-45.
151. Cahalan MD, Zhang SL, Yeromin AV et al. Molecular basis of the CRAC channel. Cell Calcium 2007; 42:133-44. (Pubitemid 47029601)
152. Mignen O, Thompson JL, Shuttleworth TJ. Orai1 subunit stoichiometry ofthe mammalian CRAC channel pore. J Physiol 2008; 586:419-25.
153. Ji W, Xu P, Li Z, Lu J, Liu L, Zhan Y et al. Functional stoichiometry ofthe unitary calcium-release-activated calcium channel. Proc Natl Acad Sci USA 2008; 105:13668-73.
154. 2+channels with distinct functional properties. Curr Biol 2007; 17:794-800. (Pubitemid 46635119)
155. Scharenberg AM, Humphries LA, Rawlings DJ. Calcium signalling and cell-fate choice in B cells. Nat Rev Immunol 2007; 7:778-89. (Pubitemid 47480308)
156. Clapham DE. Calcium signaling. Cell 2007; 131:1047-58. (Pubitemid 350258556)
157. Frischauf I, Schindl R, Derler I et al. The STIM/Orai coupling machinery. Channels (Austin ) 2008; 2:261-8.
158. Potier M, Trebak M. New developments in the signaling mechanisms of the store-operated calcium entry pathway. Pflugers Arch 2008; 457:405-15.
159. 2+signaling in T-cells. Trends Mol Med 2007; 13:103-7. (Pubitemid 46341959)
160. Feske S. Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol 2007; 7:690-702. (Pubitemid 47327393)
161. Oh-Hora M, Rao A. Calcium signaling in lymphocytes. Curr Opin Immunol 2008; 20:250-8.
162. Vig M, Kinet JP. Calcium signaling in immune cells. Nature Immunol 2009; 10:21-7.
163. 2+and Mn2+ influx through receptor-mediated activation of nonspecific cation channels in mast cells. Proc Natl Acad Sci USA 1993; 90:3068-72. (Pubitemid 23113559)
164. 2+channels in divalent cation-free solutions. J Biol Chem 2001; 12; 276:1063-70. (Pubitemid 32096529)
165. Ong HL, Cheng KT, Liu X, Bandyopadhyay BC, Paria BC, Soboloff J et al. Dynamic assembly of TRPC1-STIM1-Orai1 ternary complex is involved in store-operated calcium influx. Evidence for similarities in store-operated and calcium release-activated calcium channel components. J Biol Chem 2007; 282:9105-16. (Pubitemid 47093540)
166. Liao Y, Erxleben C, Yildirim E et al. Orai proteins interact with TRPC channels and confer responsiveness to store depletion. Proc Natl Acad Sci USA 2007; 104:4682-7. (Pubitemid 47186285)
167. 2+channels. J Biol Chem 2008; 283:25296-304.
168. Mohr FC, Fewtrell C. IgE receptor-mediated depolarization of rat basophilic leukemia cells measured with the fluorescent probe bis-oxonol. J Immunol 1987; 138:1564-70. (Pubitemid 17029458)
169. Wischmeyer E, Lentes KU, Karschin A. Physiological and molecular characterization of an IRK-type inward rectifier K+ channel in a tumour mast cell line. Pflugers Arch 1995; 429:809-19.
170. Bradding P. Mast cell ion channels. Chem Immunol Allergy 2005; 87:163-78. (Pubitemid 43093187)
171. Narenjkar J, Assem SK, Ganellin CR. Inhibition of the antigen-induced activation of RBL-2H3 cells by cetiedil and some of its analogues. Eur J Pharmacol 2004; 483:107-16. (Pubitemid 38068390)
172. 2+influx and degranulation in human lung mast cells. J Allergy Clin Immunol 2004; 114:66-72. (Pubitemid 39005119)
173. Cruse G, Duffy SM, Brightling CE et al. Functional KCA3.1 K+ channels are required for human lung mast cell migration. Thorax 2006; 61:880-5. (Pubitemid 44570309)
174. Harteneck C. Function and pharmacology of TRPM cation channels. Naunyn Schmiedebergs Arch Pharmacol 2005; 371:307-14. (Pubitemid 40905085)
175. Launay P, Fleig A, Perraud AL et al. TRPM4 is a Ca2+-activated nonselective cation channel mediating cell membrane depolarization. Cell 2002; 109:397-407. (Pubitemid 34606881)
176. Vennekens R, Olausson J, Meissner M, Bloch W, Mathar I, Philipp SE et al. Increased IgE-dependent mast cell activation and anaphylactic responses in mice lacking the calcium-activated nonselective cation channel TRPM4. Nat Immunol 2007; 8:312-20. (Pubitemid 46745381)
177. Shimizu T, Owsianik G, Freichel M et al. TRPM4 regulates migration of mast cells in mice. Cell Calcium 2009; 45:226-32.
178. 2+influx and cytokine production by facilitating transient receptor potential melastatin 4 channel activity. Mol Pharmacol 2006; 69:1413-20.
179. Strehler EE, Treiman M. Calcium pumps of plasma membrane and cell interior. Curr Mol Med 2004; 4:323-35. (Pubitemid 38515242)
180. Brini M. Plasma membrane Ca2+-ATPase: from a housekeeping function to a versatile signaling role. Pflugers Arch 2009; 457:657-64.
181. 2+pump crystal structure in the absence of Ca2+. Proc Natl Acad Sci USA 2005; 102:14489-96. (Pubitemid 41457085)
182. 2+ATPase of animal cells: structure, function and regulation. Arch Biochem Biophys 2008; 476:65-74.
183. Bautista DM, Hoth M, Lewis RS. Enhancement of calcium signalling dynamics and stability by delayed modulation of the plasma-membrane calcium-ATPase in human T-cells. J Physiol 2002; 541:877-94. (Pubitemid 35190247)
184. 2+extrusion sites in pancreatic acinar cells. J Biol Chem 1996; 271:7615-9.
185. 2+pumps in pancreatic and salivary gland cells. Role in initiation and propagation of [Ca2+]i waves. J Biol Chem 1997; 272:15771-6. (Pubitemid 27265553)
186. Jayapal M, Tay HK, Reghunathan R et al. Genome-wide gene expression profiling ofhuman mast cells stimulated by IgE or FceRI-aggregation reveals a complex network of genes involved in inflammatory responses. BMC Genomics 2006; 7:210-27.
187. 2+transport. Biochem J 2007; 406:365-82. (Pubitemid 47425443)
188. Alfonso A, Lago J, Botana MA et al. Characterization ofthe Na+/Ca2+ exchanger on rat mast cells. Evidence for a functional role on the regulation of the cellular response. Cell Physiol Biochem 1999; 9:53-71. (Pubitemid 29330968)
189. 2+transport modulates the secretory response to the Fce receptor stimulus of mast cells. Biophys J 2000; 79:2975-86.
190. 2+signaling by Na+/Ca2+ exchangers in mast cells. J Immunol 2005; 174:119-30. (Pubitemid 40007398)
191. Romagnoli A, Aguiari P, De SD et al. Endoplasmic reticulum/mitochondria calcium cross-talk. Novartis Found Symp 2007; 287:122-31.
192. Santo-Domingo J, Demaurex N. Calcium uptake mechanisms of mitochondria. Biochim Biophys Acta 2010; doi:10.1016/j.bbabio.2010.01.005.
193. Pacher P, Csordas P, Schneider T et al. Quantification of calcium signal transmissionfrom sarco-endoplasmic reticulum to the mitochondria. J Physiol 2000; 529 Pt 3:553-64. (Pubitemid 32051061)
194. Csordas G, Hajnoczky G. Sorting of calcium signals at the junctions of endoplasmic reticulum and mitochondria. Cell Calcium 2001; 29:249-62. (Pubitemid 32266392)
195. Csordas G, Hajnoczky G. Plasticity of mitochondrial calcium signaling. J Biol Chem 2003; 278:42273-82. (Pubitemid 37310495)
196. Hoth M, Button DC, Lewis RS. Mitochondrial control of calcium-channel gating: a mechanism for sustained signaling and transcriptional activation in T-lymphocytes. Proc Natl Acad Sci USA 2000; 97:10607-12.
197. 2+uptake. EMBO J 2002; 21:6744-54. (Pubitemid 36014546)
198. Park MK, Ashby MC, Erdemli G et al. Perinuclear, perigranular and sub-plasmalemmal mitochondria have distinct functions in the regulation of cellular calcium transport. EMBO J 2001; 20:1863-74. (Pubitemid 32397389)
199. Kirichok Y, Krapivinsky G, Clapham DE. The mitochondrial calcium uniporter is a highly selective ion channel. Nature 2004; 427:360-4. (Pubitemid 38133664)
200. Jiang D, Zhao L, Clapham DE. Genome-wide RNAi screen identifies Letml as a mitochondrial Ca2+/H+ antiporter. Science 2009; 326:144-7.
201. Dolman NJ, Tepikin AV. Calcium gradients and the Golgi. Cell Calcium 2006; 40:505-12. (Pubitemid 44660719)
202. Nicholls DG. Mitochondria and calcium signaling. Cell Calcium 2005; 38:311-7. (Pubitemid 41283269)
203. Nicholls DG. The regulation ofextramitochondrial free calcium ion concentration by rat liver mitochondria. Biochem J 1978; 176:463-74.
204. 2+handling in human complex I deficiency. J Biol Chem 2004; 279:40328-36. (Pubitemid 39287618)
205. Tovey SC, de SP, Lipp P et al. Calcium puffs are generic InsP3-activated elementary calcium signals and are downregulated by prolonged hormonal stimulation to inhibit cellular calcium responses. J Cell Sci 2001; 114:3979-89. (Pubitemid 33115019)
206. Berridge MJ. Calcium microdomains: organization and function. Cell Calcium 2006; 40:405-12. (Pubitemid 44752611)
207. Kalesnikoff J, Galli SJ. New developments in mast cell biology. Nat Immunol 2008; 9:1215-23.
208. Beaven M.A. Our perception of the mast cell from Paul Ehrlich to now. Eur J Immunol 2009; 39:11-25.
209. Hirasawa N, Santini F, Beaven M.A. Activation of the mitogen-activated protein kinase/cytosolic phospholipase A2 pathway in a rat mast cell line. Indications ofdifferent pathways for release ofarachidonic acid and secretory granules. J Immunol 1995; 154:5391-402.
210. Wodnar-Filipowicz A, Moroni C. Regulation of interleukin 3 mRNA expression in mast cells occurs at the posttranscriptional level and is mediated by calcium ions. Proc Natl Acad Sci USA 1990; 87:777-81.
211. Plaut M, Pierce JH, Watson CJ et al. Mast cell lines produce lymphokines in response to cross-linkage of FceRI or to calcium ionophores. Nature 1989; 339:64-7. (Pubitemid 19115894)
212. Burd PR, Rogers HW, Gordon JR et al. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 1989; 170:245-57. (Pubitemid 19179708)
213. Thompson HL, Burbelo PD, Yamada Y et al. Mast cells chemotax to laminin with enhancement after IgE-mediated activation. J Immunol 1989; 143:4188-92. (Pubitemid 20012613)
214. Hofstra CL, Desai PJ, Thurmond RL et al. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J Pharmacol Exp Ther 2003; 305:1212-21. (Pubitemid 36618001)
215. Benyon RC, Robinson C, Church MK. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli. Brit J Pharmacol 1989; 97:898-904. (Pubitemid 19168725)
216. van Haaster CM, Engels W, Lemmens PJ et al. Differential release of histamine and prostaglandin D2 in rat peritoneal mast cells: roles of cytosolic calcium and protein tyrosine kinases. Biochim Biophys Acta 1995; 1265:79-88.
217. 2+responses and secretion in individual RBL-2H3 mucosal mast cells. J Biol Chem 1997; 272:31225-9. (Pubitemid 28013251)
218. Chang WC, Di CJ, Nelson C et al. All-or-none activation of CRAC channels by agonist elicits graded responses in populations of mast cells. J Immunol 2007; 179:5255-63.
219. Ramkumar V, Stiles GL, Beaven MA et al. The A3R is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 1993; 268:16887-90. (Pubitemid 23236909)
220. Sweeney ZK, Minatti A, Button DC et al. Small-molecule inhibitors of store-operated calcium entry. ChemMedChem 2009; 4:706-18.
221. Sureshan KM, Trusselle M, Tovey SC et al. 2-Position base-modified analogues of adenophostin A as high-affinity agonists of the D-myo-inositol trisphosphate receptor: in vitro evaluation and molecular modeling. J Org Chem 2008; 73:1682-92. (Pubitemid 351438883)
222. Takahashi M, Tanzawa K, Takahashi S. Adenophostins, newly discovered metabolites of Penicillium brevicompactum, act as potent agonists of the inositol 1,4,5-trisphosphate receptor. J Biol Chem 1994; 269:369-72. (Pubitemid 24026668)
223. Hirota J, Michikawa T, Miyawaki Aet al. Adenophostin-mediated quantal Ca2t release in the purified and reconstituted inositol 1,4,5-trisphosphate receptor type 1. FEBS Lett 1995; 368:248-52.
224. Huang Y, Takahashi M, Tanzawa K et al. Effect ofadenophostin A on Ca2t entry and calcium release-activated calcium current (Icrac) in rat basophilic leukemia cells. J Biol Chem 1998; 273:31815-21. (Pubitemid 29177116)
225. Bird GS, Takahashi M, Tanzawa K et al. Adenophostin A induces spatially restricted calcium signaling in Xenopus laevis oocytes. J Biol Chem 1999; 274:20643-9.
226. Gafni J, Munsch JA, Lam TH et al. Xestospongins: potent membrane permeable blockers of the inositol 1,4,5-trisphosphate receptor. Neuron 1997; 19:723-33. (Pubitemid 27430757)
227. Castonguay A, Robitaille R. Xestospongin C is a potent inhibitor of SERCA at a vertebrate synapse. Cell Calcium 2002; 32:39-47. (Pubitemid 34966026)
228. Solovyova N, Fernyhough P, Glazner G et al. Xestospongin C empties the ER calcium store but does not inhibit InsP3-induced Ca2t release in cultured dorsal root ganglia neurones. Cell Calcium 2002; 32:49-52. (Pubitemid 34966027)
229. Oka T, Sato K, Hori M et al. Xestospongin C, a novel blocker of IP3 receptor, attenuates the increase in cytosolic calcium level and degranulation that is induced by antigen in RBL-2H3 mast cells. Br J Pharmacol 2002; 135:1959-66. (Pubitemid 34478308)
230. Rasmussen U, Broogger CS, Sandberg F. Thapsigargin and thapsigargicin, two new histamine liberators from Thapsia garganica L. Acta Pharm Suec 1978; 15:133-40. (Pubitemid 8368936)
231. Patkar SA, Rasmussen U, Diamant B. On the mechanism of histamine release induced by thapsigargin from Thapsia garganica L. Agents Actions 1979; 9:53-7. (Pubitemid 9157246)
232. Ali H, Christensen SB, Foreman JC et al. The ability of thapsigargin and thapsigargicin to activate cells involved in the inflammatory response. Br J Pharmacol 1985; 85:705-12. (Pubitemid 15028813)
233. Xu C, Ma H, Inesi G. Specific structural requirements for the inhibitory effect of thapsigargin on the Ca2t ATPase SERCA. J Biol Chem 2004; 279:17973-9. (Pubitemid 38560566)
234. Wootton LL, Michelangeli F. The effects of the phenylalanine 256 to valine mutation on the sensitivity of sarcoplasmic/endoplasmic reticulum Ca2t ATPase (SERCA) Ca2t pump isoforms 1, 2 and 3 to thapsigargin and other inhibitors. J Biol Chem 2006; 281:6970-6. (Pubitemid 43847459)
235. Sagara Y, Inesi G. Inhibition of the sarcoplasmic reticulum Ca2t transport ATPase by thapsigargin at subnanomolar concentrations. J Biol Chem 1991; 266:13503-6. (Pubitemid 21907377)
236. Oka T, Hori M, Ozaki H. Microtubule disruption suppresses allergic response through the inhibition of calcium influx in the mast cell degranulation pathway. J Immunol 2005; 174:4584-9.
237. Ma HT, Patterson RL, van Rossum DB et al. Requirement of the inositol trisphosphate receptor for activation of store-operated Ca2t channels. Science 2000; 287:1647-51. (Pubitemid 30127765)
238. Bootman MD, Collins TJ, Mackenzie L et al. 2-Aminoethoxydiphenyl borate (2-APB) is a reliable blocker of store-operated Ca2t entry but an inconsistent inhibitor of InsP3-induced Ca2t release. FASEB J 2002; 16:1145-50. (Pubitemid 34815402)
239. Prakriya M, Lewis RS. Potentiation and inhibition of Ca2t release-activated Ca2t channels by 2-aminoethyldiphenyl borate (2-APB) occurs independently of IP3 receptors. J Physiol 2001; 536:3-19. (Pubitemid 32952214)
240. Zhang SL, Kozak JA, Jiang W et al. Store-dependent and -independent modes regulating Ca2t release-activated Ca2t channel activity of human Orai1 and Orai3. J Biol Chem 2008; 283:17662-71.
241. Peinelt C, Lis A, Beck A et al. 2-Aminoethoxydiphenyl borate directly facilitates and indirectly inhibits STIM1 -dependent gating of CRAC channels. J Physiol 2008; 586:3061-73. (Pubitemid 351984690)
242. Dehaven WI, Smyth JT, Boyles RR et al. Complex actions of2-aminoethyldiphenyl borate on store-operated calcium entry. J Biol Chem 2008; 283:19265-73.
243. Schindl R, Bergsmann J, Frischauf I et al. 2-Aminoethoxydiphenyl borate alters selectivity of Orai3 channels by increasing their pore size. J Biol Chem 2008; 283:20261-7.
244. Aksoy E, Goldman M, Willems F. Protein kinase C epsilon: a new target to control inflammation and immune-mediated disorders. Int J Biochem Cell Biol 2004; 36:183-8. (Pubitemid 37487754)
245. Ishikawa J, Ohga K, Yoshino T et al. A pyrazole derivative, YM-58483, potently inhibits store-operated sustained Ca2t influx and IL-2 production in T-lymphocytes. J Immunol 2003; 170:4441-9. (Pubitemid 36519948)
246. He LP, Hewavitharana T, Soboloff J et al. A functional link between store-operated and TRPC channels revealed by the 3,5-bis(trifluoromethyl) pyrazole derivative, BTP2. J Biol Chem 2005; 280:10997-1006. (Pubitemid 40418402)
247. Yoshino T, Ishikawa J, Ohga K et al. YM-58483, a selective CRAC channel inhibitor, prevents antigen-induced airway eosinophilia and late phase asthmatic responses via Th2 cytokine inhibition in animal models. Eur J Pharmacol 2007; 560:225-33. (Pubitemid 46341302)
248. 2+entry blocker, on inflammatory mediator release in vitro and airway responses in vivo. Pulm Pharmacol Ther 2008; 21:360-9. (Pubitemid 351312679)
249. de Lumley M, Hart DJ, Cooper MA et al. A biophysical characterisation of factors controlling dimerisation and selectivity in the NF-KB and NFAT families. J Mol Biol 2004; 339:1059-75. (Pubitemid 39303249)
250. Dunlop J, Bowlby M, Peri R et al. High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiology. Nat Rev Drug Discov 2008; 7:358-68.
251. 2+channel activation and altered K+ channel gating in T-cells from immunodeficient patients. J Exp Med 2005; 202:651-62. (Pubitemid 41248416)
252. Picard C, McCarl CA, Papolos A et al. STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N Engl J Med 2009; 360:1971-80.
253. 2+pump, cause Darier disease. Nat Genet 1999; 21:271-7. (Pubitemid 29124933)
254. Kruse M, Schulze-Bahr E, Corfield V et al. Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I. J Clin Invest 2009; 119:2737-44.
255. Reiser J, Polu KR, Moller CC et al. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet 2005; 37:739-44. (Pubitemid 41754891)
256. Winn MP, Conlon PJ, Lynn KL et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 2005; 308:1801-4. (Pubitemid 40848011)
257. Abramowitz J, Birnbaumer L. Know thy neighbor: a survey of diseases and complex syndromes that map to chromosomal regions encoding TRP channels. Handb Exp Pharmacol 2007:379-408.
258. Abramowitz J, Birnbaumer L. Physiology and pathophysiology of canonical transient receptor potential channels. FASEB J 2009; 23:297-328.